Tremblay Bénédicte L, Bégin Philippe, Gagnon-Brassard Frédérique, Boucher-Lafleur Anne-Marie, Lavoie Marie-Ève, Madore Anne-Marie, Lavoie Sarah, Rochefort-Beaudoin Cloé, Nuncio-Naud Claudia, Morin Charles, Parizeault Guy, Laprise Catherine
Département des sciences fondamentales, Université du Québec à Chicoutimi, 555 Boulevard de l'Université, Saguenay, QC, G7H 2B1, Canada.
Centre intersectoriel en santé durable, Université du Québec à Chicoutimi, Saguenay, QC, Canada.
Allergy Asthma Clin Immunol. 2024 Nov 2;20(1):59. doi: 10.1186/s13223-024-00921-8.
The Zéro allergie research clinic (Saguenay, Canada) is a clinical and research initiative in oral immunotherapy (OIT) for managing IgE-mediated food allergy (FA). A total of 183 children with FA and 27 non-allergic siblings were recruited to date in the Zéro allergie cohort (ZAC) to better understand biological mechanisms underlying FA and OIT prognosis. The primary aims are to (a) better understand the genetic, epigenetic, transcriptomic, metabolomic, and microbial diversity associated with FA; (b) establish the multi-omics and microbial diversity profiles of children following OIT to identify predictive prognosis biomarkers, (c) make OIT more accessible to the population of the Saguenay-Lac-Saint-Jean region, and (d) build a biobank of data and biological material.
The ZAC constitutes a unique and rich biobank of biological samples (blood, buccal swabs, microbiota samples [intestinal, buccal, nasal, and cutaneous]) combined with clinical data and more than 75 phenotypic characteristics.
This represents an innovative interdisciplinary initiative by researchers, allergists, and paediatricians to make FA care accessible to a greater number of children with IgE-mediated FA. Ultimately, it will contribute to provide more accessible treatment options with greater chances of success through a better understanding of the biological nature of FA and OIT.
零过敏研究诊所(加拿大萨格奈)是一项针对IgE介导的食物过敏(FA)进行口服免疫疗法(OIT)的临床与研究项目。截至目前,零过敏队列(ZAC)已招募了183名患有食物过敏的儿童和27名非过敏的兄弟姐妹,以更好地了解食物过敏和口服免疫疗法预后的潜在生物学机制。主要目标包括:(a)更好地了解与食物过敏相关的基因、表观遗传、转录组、代谢组和微生物多样性;(b)确定接受口服免疫疗法后儿童的多组学和微生物多样性特征,以识别预测预后的生物标志物;(c)使萨格奈-圣让湖地区的人群更容易获得口服免疫疗法;(d)建立一个数据和生物材料生物样本库。
ZAC构成了一个独特且丰富的生物样本库,包含生物样本(血液、口腔拭子、微生物群样本[肠道、口腔、鼻腔和皮肤])以及临床数据和75种以上的表型特征。
这是研究人员、过敏症专科医生和儿科医生发起的一项创新的跨学科项目,旨在让更多患有IgE介导的食物过敏的儿童能够获得食物过敏治疗。最终,通过更好地了解食物过敏和口服免疫疗法的生物学本质,它将有助于提供更容易获得且成功几率更高的治疗选择。